TD Private Client Wealth’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $169K | Buy |
+2,156
| New | +$169K | ﹤0.01% | 672 |
|
|
2025
Q1 | – | Sell |
-2,137
| Closed | -$158K | – | 1439 |
|
|
2024
Q4 | $158K | Sell |
2,137
-1,209
| -36% | -$89.5K | ﹤0.01% | 647 |
|
|
2024
Q3 | $221K | Sell |
3,346
-17,777
| -84% | -$1.17M | 0.01% | 581 |
|
|
2024
Q2 | $1.95M | Sell |
21,123
-1,583
| -7% | -$146K | 0.06% | 238 |
|
|
2024
Q1 | $2.17M | Sell |
22,706
-1,514
| -6% | -$145K | 0.07% | 220 |
|
|
2023
Q4 | $1.85M | Buy |
24,220
+8,064
| +50% | +$615K | 0.07% | 234 |
|
|
2023
Q3 | $1.12M | Buy |
16,156
+274
| +2% | +$19K | 0.05% | 304 |
|
|
2023
Q2 | $1.5M | Buy |
15,882
+1,242
| +8% | +$117K | 0.06% | 266 |
|
|
2023
Q1 | $1.21M | Buy |
14,640
+220
| +2% | +$18.2K | 0.05% | 295 |
|
|
2022
Q4 | $1.08M | Sell |
14,420
-14,001
| -49% | -$1.04M | 0.05% | 313 |
|
|
2022
Q3 | $2.35M | Sell |
28,421
-609
| -2% | -$50.3K | 0.12% | 177 |
|
|
2022
Q2 | $2.77M | Sell |
29,030
-145
| -0.5% | -$13.8K | 0.13% | 161 |
|
|
2022
Q1 | $3.43M | Buy |
29,175
+3,158
| +12% | +$372K | 0.15% | 151 |
|
|
2021
Q4 | $3.37M | Sell |
26,017
-4,029
| -13% | -$522K | 0.14% | 161 |
|
|
2021
Q3 | $3.4M | Buy |
30,046
+16,956
| +130% | +$1.92M | 0.15% | 156 |
|
|
2021
Q2 | $1.36M | Buy |
13,090
+312
| +2% | +$32.3K | 0.06% | 295 |
|
|
2021
Q1 | $1.07M | Buy |
12,778
+1,097
| +9% | +$91.8K | 0.05% | 307 |
|
|
2020
Q4 | $1.07M | Buy |
11,681
+1,460
| +14% | +$133K | 0.05% | 292 |
|
|
2020
Q3 | $816K | Sell |
10,221
-907
| -8% | -$72.4K | 0.05% | 310 |
|
|
2020
Q2 | $769K | Buy |
11,128
+3,406
| +44% | +$235K | 0.04% | 312 |
|
|
2020
Q1 | $486K | Sell |
7,722
-1,194
| -13% | -$75.1K | 0.03% | 325 |
|
|
2019
Q4 | $693K | Buy |
+8,916
| New | +$693K | 0.04% | 310 |
|